2021 World Tumor Markers Market Assessment of 97 Countries--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is available by section, and can be customized to specific information needs and budget.

This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.

The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Regions and Countries

Asia-Pacific

Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

Europe

Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine

Latin America

Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela

Middle East

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

North America

Canada, Mexico, USA

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Tests

- Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines

- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers in major countries by individual test.

- Five-year test volume and sales forecasts for major cancer diagnostic assays.

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include: Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Fujirebio, Grifols, Hologic, Leica Biosystems, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen, Roche, Siemens Healthineers, Takara Bio, Thermo Fisher, Wako and others.

Contains 1,515 pages and 626 tables

This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.

I. Inroducion
II. Worldwide Marke Overview
III. Major Produc Developmen Opporuniies
A. Reagen Kis and es Sysems/Panels
B. Insrumenaion
C. Compuers, Sofware and Auomaion
D. Auxiliary Producs
IV. Design Crieria for Decenralized esing Producs
V. Alernaive Marke Peneraion Sraegies
A. Inernal Developmen
B. Collaboraive Arrangemens
C. Universiy Conracs
D. Disribuion Sraegies
VI. Poenial Marke Enry Barriers and Risks
A. Marke Mauriy
B. Cos Conainmen
C. Compeiion
D. echnological Edge and Limiaions
E. Paen Proecion
F. Regulaory Consrains
G. Decenralized esing Marke Challenges
VII. Worldwide Marke and echnology Overview
A. Cancer Saisics and Eiology
1. Breas Cancer
2. Lung Cancer
3. Colon and Recum Cancer
4. Prosae Cancer
5. Somach Cancer
6. Leukemia
7. Lymphoma
8. Oral Cancer
9. Skin Cancer
10. Uerine Cancer
11. Ovarian Cancer
12. Bladder Cancer
B. Major Curren and Emerging Cancer Diagnosic ess
1. Inroducion
2. umor Marker Classificaion
3. ACH
4. Alpha-Feoproein (AFP)
5. Bea-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcionin
10. Carcinoembrionic Anigen (CEA)
11. Esrogen and Progeserone Recepors
12. Ferriin
13. Gasrin
14. Human Chorionic Gonadoropin (HCG)
15. Insulin
16. NSE
17. Occul Blood
18. PAP Smear/HPV
19. Prosaic Acid Phosphaase (PAP)
20. Prosae-Specific Anigen (PSA)
21. Squamous Cell Carcinoma Anigen (SCC)
22.  and B Lymphocyes
23. d
24. hyroglobulin
25. issue Polypepide Anigen (PA)
26. Biochemical umor Markers
27. Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP-17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PI-1
- Ras
- Reg
- Sis
- Src and ohers
28. Polypepide Growh Facors
- Basic Fibroblas Growh Facor
- Bea-GF
- Cachecin (N)
- Calmodulin
- ECFR
- Nerve Growh Facor (NGF)
- Epidermal Growh Facor (EGF)
- Ornihine Decarboxylase
- ransferrin
- ransforming Growh Facor-Alpha
29. Ecopic Hormones
30. Colony Simulaing Facors
31. Lymphokines
- Alpha-Inerferon
- B Cell Growh Facors
- B Cell Growh Facor (BCGF)
- Gamma-Inerferon
- Inerleukin-1 (IL-1)
- Macrophage Acivaing Facor
32. Immunohisochemical Sains
33. Emerging umor Markers
- N-Aceylglucosamine
- Acin
- Alpha-Acin
- Anineuronal Anibodies
- 7B2
- B72.3
- Bax
- BCD-F9
- BLCA-4
- Blood Group Anigens A,B,H
- CA 50
- CA 72-4/AG-72
- CA 195
- CA-242
- CA-549
- CAM 26
- CAR-3
- Cahepsin-D
- Chromogranin A and B
- Cluser 1 Anigen
- Cluser-5/5A Anigen
- CA
- CU18
- DR-70
- DU-PAN-2
- Endomerial Bleeding Associaed Facor
- Endosain
- Epihelial Membrane Anigen
- Feulgen Hydrolysis
- Fibronecin
- FSH
- (1->3)-L-fucosylransferase
- Gasrin-Releasing Pepide (GRP)
- GDCFP-15
- Glucagon
- Glycoamines
- H23
- Her-2
- Human Carcinoma Anigen
- HPA
- HSP27
- Inermediae Filamens
- Cyokerains/CK18/Cyfra 21-1
- Desmin
- Gliofibrillary Acid Proein
- Neurofilamens
- Vimenin
- KA 93
- Kinases
- KP16D3
- LAI
- Leukocye Common Anigen
- Lewis Anigens
- Lysophosphaidic Acid (LPA)
- Ma 695/Ma 552
- MABDF3
- MAG
- ME1
- Minacivin
- MN/CA9
- MSA
- Mucin Cancer Anigen (MCA)
- Muliple umor Suppressor 1
- Myosin
- NEA-130
- NMP22
- OA-519
- Opioid Pepides
- P-glycoproein
- Pancreaic Oncofeal Anigen (POA)
- Placenal Lacogen
- PR92
- Proliferaive Index, Ki-67
- Px
- RB Inacivaion/Deleion
- Re
- SCCL 175
- Selecin
- Sialic Acid
- Sialyl SSEA-1/SLX
- SN10
- Somaosain
- A-90
- ABA
- achykinin
- AG 12
- PS
- roponin
- ubulin
- VCAM
- VEGF
- Villen and ohers
C. Cancer Diagnosic esing Insrumenaion Review and Marke Needs
D. Curren and Emerging Cancer Diagnosic echnologies
1. Monoclonal and Polyclonal Anibodies
2. Immunoassays
3. Molecular Diagnosics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acue Myeloid Leukemia (AML)
c. Acue Lymphoblasic Leukemia (ALL)
d. Malignan Lymphomas Lymphoid Malignancies
e. Chronic Lymphocyic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal ranslocaion and Oncogenes
5. Arificial Inelligence
6. Flow Cyomery
7. wo Dimensional Gel Elecrophoresis (2-DGE)
8. Biosensors
9. Compeing/Complemening echnologies
E. Personal esing
VIII. Counry Marke Analyses: Cancer Diagnosics Marke es
Volume and Sales Forecass for 97 Counries:
Albania, Algeria, Argenina, Ausralia, Ausria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil,
Bulgaria, Canada, Chile, China, Colombia, Cosa Rica, Croaia, Cuba, Cyprus, Czech Republic,
Denmark, Dominican Republic, Ecuador, Egyp, El Salvador, Esonia, Finland, France, Georgia,
Germany, Ghana, Greece, Guaemala, Haii, Honduras, Hong Kong, Hungary, Iceland, India,
Indonesia, Iran, Iraq, Ireland, Israel, Ialy, Jamaica, Japan, Jordan, Kazakhsan, Kenya, Kuwai, Lavia,
Lebanon, Lihuania, Malaysia, Mala, Mexico, Moldova, Morocco, Myanmar, Neherlands, New
Zealand, Nicaragua, Nigeria, Norway, Oman, Pakisan, Panama, Paraguay, Peru, Philippines, Poland,
Porugal, Puero Rico, Qaar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic,
Slovenia, Souh Korea, Souh Africa, Spain, Sweden, Swizerland, aiwan, hailand, UK, Ukraine,
Unied Arab Emiraes, Uruguay, USA, Venezuela, Vienam
IX. Compeiive Profiles
he repor provides sraegic assessmens of over 30 leading cancer diagnosics marke players
and sar-up companies wih innovaive echnologies and producs, including:
- Abbo
- Affymerix
- Beckman Couler/Danaher
- Becon Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- DiaSorin
- Eiken Chemical
- Eliech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic
- Leica Biosysems
- Orho-Clinical Diagnosics
- PerkinElmer
- Qiagen
- Roche
- Siemens Healhineers
- akara Bio
- hermo Fisher
- Wako and ohers.

List Of Tables

Argentina Cancer Diagnostic Volume Forecasts by Test
Argentina Cancer Diagnostics Sales Forecasts by Test
Australia Cancer Diagnostic Volume Forecasts by Test
Australia Cancer Diagnostics Sales Forecasts by Test
Austria Cancer Diagnostic Volume Forecasts by Test
Austria Cancer Diagnostics Sales Forecasts by Test
Bahrain Cancer Diagnostic Volume Forecasts by Test
Bahrain Cancer Diagnostics Sales Forecasts by Test
Bangladesh Cancer Diagnostic Volume Forecasts by Test
Bangladesh Cancer Diagnostics Sales Forecasts by Test
Belgium Cancer Diagnostic Volume Forecasts by Test
Belgium Cancer Diagnostics Sales Forecasts by Test
Brazil Cancer Diagnostic Volume Forecasts by Test
Brazil Cancer Diagnostics Sales Forecasts by Test
Bulgaria Cancer Diagnostic Volume Forecasts by Test
Bulgaria Cancer Diagnostics Sales Forecasts by Test
Canada Cancer Diagnostic Volume Forecasts by Test
Canada Cancer Diagnostics Sales Forecasts by Test
Chile Cancer Diagnostic Volume Forecasts by Test
Chile Cancer Diagnostics Sales Forecasts by Test
China Cancer Diagnostic Volume Forecasts by Test
China Cancer Diagnostics Sales Forecasts by Test
Colombia Cancer Diagnostic Volume Forecasts by Test
Colombia Cancer Diagnostics Sales Forecasts by Test
Croatia Cancer Diagnostic Volume Forecasts by Test
Croatia Cancer Diagnostics Sales Forecasts by Test
Cyprus Cancer Diagnostic Volume Forecasts by Test
Cyprus Cancer Diagnostics Sales Forecasts by Test
Czech Republic Cancer Diagnostic Volume Forecasts by Test
Czech Republic Cancer Diagnostics Sales Forecasts by Test
Denmark Cancer Diagnostic Volume Forecasts by Test
Denmark Cancer Diagnostics Sales Forecasts by Test
Egypt Cancer Diagnostic Volume Forecasts by Test
Egypt Cancer Diagnostics Sales Forecasts by Test
Estonia Cancer Diagnostic Volume Forecasts by Test
Estonia Cancer Diagnostics Sales Forecasts by Test
Finland Cancer Diagnostic Volume Forecasts by Test
Finland Cancer Diagnostics Sales Forecasts by Test
France Executive Summary Table: Total Cancer
Diagnostic Test Volume and Sales Forecast
by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Gastrin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Interferons Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Interleukins Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test Volume
and Diagnostics Sales Forecast by Market Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test Volume
and Diagnostics Sales Forecast by Market Segment
France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market Segment
France, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume
and Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales
by Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Germany Executive Summary Table: Total
Tumor Marker Test Volume and Sales Forecast
by Market Segment
Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume
and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume
and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Chromogranin Test Volume
and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales
by Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Ghana Cancer Diagnostic Volume Forecasts by Test
Ghana Cancer Diagnostics Sales Forecasts by Test
Greece Cancer Diagnostic Volume Forecasts by Test
Greece Cancer Diagnostics Sales Forecasts by Test
Hong Kong Cancer Diagnostic Volume Forecasts by Test
Hong Kong Cancer Diagnostics Sales Forecasts by Test
Hungary Cancer Diagnostic Volume Forecasts by Test
Hungary Cancer Diagnostics Sales Forecasts by Test
Iceland Cancer Diagnostic Volume Forecasts by Test
Iceland Cancer Diagnostics Sales Forecasts by Test
India Cancer Diagnostic Volume Forecasts by Test
India Cancer Diagnostics Sales Forecasts by Test
Indonesia Cancer Diagnostic Volume Forecasts by Test
Indonesia Cancer Diagnostics Sales Forecasts by Test
Iran Cancer Diagnostic Volume Forecasts by Test
Iran Cancer Diagnostics Sales Forecasts by Test
Iraq Cancer Diagnostic Volume Forecasts by Test
Iraq Cancer Diagnostics Sales Forecasts by Test
Ireland Cancer Diagnostic Volume Forecasts by Test
Ireland Cancer Diagnostics Sales Forecasts by Test
Israel Cancer Diagnostic Volume Forecasts by Test
Israel Cancer Diagnostics Sales Forecasts by Test
Italy Executive Summary Table: Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume
and Diagnostics Sales Forecast by Market Segment
Italy, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Chromogranin Test Volume
and Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume
and Diagnostics Sales Forecast by Market Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast
by Market Segment
Italy, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast
by Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Japan Executive Summary Table: Total Tumor
Marker Test Volume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates
Per 100,000 Population
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Tumor Marker Tests
by Annual Test Volume
Japan, Total Tumor Marker Testing Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Total Tumor Marker
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Jordan Cancer Diagnostic Volume Forecasts by Test
Jordan Cancer Diagnostics Sales Forecasts by Test
Kenya Cancer Diagnostic Volume Forecasts by Test
Kenya Cancer Diagnostics Sales Forecasts by Test
Kuwait Cancer Diagnostic Volume Forecasts by Test
Kuwait Cancer Diagnostics Sales Forecasts by Test
Latvia Cancer Diagnostic Volume Forecasts by Test
Latvia Cancer Diagnostics Sales Forecasts by Test
Lebanon Cancer Diagnostic Volume Forecasts by Test
Lebanon Cancer Diagnostics Sales Forecasts by Test
Lithuania Cancer Diagnostic Volume Forecasts by Test
Lithuania Cancer Diagnostics Sales Forecasts by Test
Malaysia Cancer Diagnostic Volume Forecasts by Test
Malaysia Cancer Diagnostics Sales Forecasts by Test
Malta Cancer Diagnostic Volume Forecasts by Test
Malta Cancer Diagnostics Sales Forecasts by Test
Mexico Cancer Diagnostic Volume Forecasts by Test
Mexico Cancer Diagnostics Sales Forecasts by Test
Morocco Cancer Diagnostic Volume Forecasts by Test
Morocco Cancer Diagnostics Sales Forecasts by Test
Myanmar Cancer Diagnostic Volume Forecasts by Test
Myanmar Cancer Diagnostics Sales Forecasts by Test
Netherlands Cancer Diagnostic Volume Forecasts by Test
Netherlands Cancer Diagnostics Sales Forecasts by Test
New Zealand Cancer Diagnostic Volume Forecasts by Test
New Zealand Cancer Diagnostics Sales Forecasts by Test
Nigeria Cancer Diagnostic Volume Forecasts by Test
Nigeria Cancer Diagnostics Sales Forecasts by Test
Norway Cancer Diagnostic Volume Forecasts by Test
Norway Cancer Diagnostics Sales Forecasts by Test
Oman Cancer Diagnostic Volume Forecasts by Test
Oman Cancer Diagnostics Sales Forecasts by Test
Pakistan Cancer Diagnostic Volume Forecasts by Test
Pakistan Cancer Diagnostics Sales Forecasts by Test
Peru Cancer Diagnostic Volume Forecasts by Test
Peru Cancer Diagnostics Sales Forecasts by Test
Philippines Cancer Diagnostic Volume Forecasts by Test
Philippines Cancer Diagnostic Volume Forecasts by Test
Poland Cancer Diagnostics Sales Forecasts by Test
Poland Cancer Diagnostic Volume Forecasts by Test
Portugal Cancer Diagnostics Sales Forecasts by Test
Portugal Cancer Diagnostic Volume Forecasts by Test
Qatar Cancer Diagnostic Volume Forecasts by Test
Qatar Cancer Diagnostics Sales Forecasts by Test
Romania Cancer Diagnostic Volume Forecasts by Test
Romania Cancer Diagnostics Sales Forecasts by Test
Saudi Arabia Cancer Diagnostic Volume Forecasts by Test
Saudi Arabia Cancer Diagnostics Sales Forecasts by Test
Serbia Cancer Diagnostic Volume Forecasts by Test
Serbia Cancer Diagnostics Sales Forecasts by Test
Singapore Cancer Diagnostic Volume Forecasts by Test
Singapore Cancer Diagnostics Sales Forecasts by Test
Slovakia Cancer Diagnostic Volume Forecasts by Test
Slovakia Cancer Diagnostics Sales Forecasts by Test
Slovenia Cancer Diagnostic Volume Forecasts by Test
Slovenia Cancer Diagnostics Sales Forecasts by Test
South Africa Cancer Diagnostic Volume Forecasts by Test
South Africa Cancer Diagnostics Sales Forecasts by Test
South Korea Cancer Diagnostic Volume Forecasts by Test
South Korea Cancer Diagnostics Sales Forecasts by Test
Spain Executive Summary Table: Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volume
and Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume
and Diagnostics Sales Forecast
by Market Segment
Spain, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volume and
Diagnostics Sales Forecast
by Market Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales
by Major Suppliers
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Sweden Cancer Diagnostic Volume Forecasts by Test
Sweden Cancer Diagnostics Sales Forecasts by Test
Switzerland Cancer Diagnostic Volume Forecasts by Test
Switzerland Cancer Diagnostics Sales Forecasts by Test
Taiwan Cancer Diagnostic Volume Forecasts by Test
Taiwan Cancer Diagnostics Sales Forecasts by Test
Thailand Cancer Diagnostic Volume Forecasts by Test
Thailand Cancer Diagnostics Sales Forecasts by Test
U.K. Executive Summary Table: Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume
Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume
and Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and
Diagnostics Sales Forecast
by Market Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and
Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
United Arab Emirates Cancer Diagnostic Volume Forecasts by Test
United Arab Emirates Cancer Diagnostics Sales Forecasts by Test
U.S.A. Executive Summary Table: Total Tumor
Marker Test Volume and Sales Forecast
by Market Segment
U.S.A., Estimated New Cancer Cases and Deaths
U.S.A., Estimated Cancer Death Rates
Per 100,000 Population
U.S.A., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Tumor Marker Tests
by Annual Test Volume
U.S.A., Physician Office Laboratories
Performing Tumor Marker Tests
by Practice Size
U.S.A., Total Tumor Marker Test Volume
Forecast by Market Segment
U.S.A., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S.A., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Test Volume Forecast
U.S.A., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Total Tumor Marker Sales
Forecast by Market Segment
U.S.A., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S.A., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S.A., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S.A., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S.A., Chromogranin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., Colon-specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
U.S.A., Cytokeratins Test Volume
and Diagnostics Sales Forecast
by Market Segment
U.S.A., Estrogen Receptor Test Volume
and Diagnostics Sales Forecast
by Market Segment
U.S.A., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Interferons Test Volume
and Diagnostics Sales Forecast by Market Segment
U.S.A., Interleukins Test Volume
and Diagnostics Sales Forecast
by Market Segment
U.S.A., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Occult Blood Test Volume
and Diagnostics Sales Forecast
by Market Segment
U.S.A., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Total Tumor Marker Sales
by Major Supplier
U.S.A., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S.A., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Beta-2 Migroblolulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 19-9 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 125 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CEA Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Parathyroid Hormone Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Progesterone Receptor Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PSA Testing Market Diagnostics
Sales by Major Supplier
Venezuela Cancer Diagnostic Volume Forecasts by Test
Venezuela Cancer Diagnostics Sales Forecasts by Test
Vietnam Cancer Diagnostic Volume Forecasts by Test
Vietnam Cancer Diagnostics Sales Forecasts by Test
Tumor Marker Classification
Major Companies Developing or
Marketing ACTH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing Beta-2 Microglobulin Tests
Major Companies Developing or
Marketing CA 15-3/27.29 Tests
Major Companies Developing or
Marketing CA 19-9 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing Calcitonin Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Gastrin Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing Insulin Tests
Major Companies Developing or
Marketing NSE Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or
Marketing PAP Smear/HPV Tests
Major Companies Developing or
Marketing PAP Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or
Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
in Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis

Fill The Form For Sample Request

There is no Reviews available